Electronically monitored adherence in outpatients with schizophrenia or schizoaffective disorder: A comparison of first- vs. second-generation antipsychotics

Paul A. Nakonezny, Matthew J. Byerly

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Objective: To examine the effect of first- vs. second-generation antipsychotics on electronically monitored adherence in outpatients with schizophrenia or schizoaffective disorder. Method: The sample consisted of 61 outpatients with a DSM-IV diagnosis of schizophrenia or schizoaffective disorder who took either a first-generation (N = 25) or second-generation (N = 36) oral antipsychotic during study participation. Treatment group designation (first-vs. second-generation antipsychotic) was based on the particular antipsychotic medication the patient was receiving as part of routine care at study entry (i.e., non-random assignment). Adherence to prescribed antipsychotic medication was assessed monthly over a 6-month study period using electronic monitoring (EM) of medication bottle opening. Various participant characteristics were collected at baseline to test for group differences and for potential associations with prospectively measured adherence. The primary data analysis was a mixed-model analysis of repeated measures. Results: The analysis of EM adherence revealed no significant difference between those taking first-generation (6-month adjusted mean adherence = 64.35%) and second-generation antipsychotics (6-month adjusted mean adherence = 69.17%; Group effect, p = .29) and no significant Group X Period interaction (p = .13). Conclusion: There was no statistical difference in EM adherence, over a 6-month period, between patients taking first- and second-generation antipsychotics. However, since the patients were not randomized, conclusions must be interpreted within the context of the quasi-experimental design used in the current study.

Original languageEnglish (US)
Pages (from-to)107-114
Number of pages8
JournalSchizophrenia Research
Volume82
Issue number1
DOIs
StatePublished - Feb 15 2006

Fingerprint

Psychotic Disorders
Antipsychotic Agents
Schizophrenia
Outpatients
Diagnostic and Statistical Manual of Mental Disorders
Research Design

Keywords

  • Antipsychotic medication adherence
  • Medication adherence
  • Schizophrenia

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Behavioral Neuroscience
  • Biological Psychiatry
  • Neurology
  • Psychology(all)

Cite this

@article{016a6e8c8e474b50b1a101d5c984bc50,
title = "Electronically monitored adherence in outpatients with schizophrenia or schizoaffective disorder: A comparison of first- vs. second-generation antipsychotics",
abstract = "Objective: To examine the effect of first- vs. second-generation antipsychotics on electronically monitored adherence in outpatients with schizophrenia or schizoaffective disorder. Method: The sample consisted of 61 outpatients with a DSM-IV diagnosis of schizophrenia or schizoaffective disorder who took either a first-generation (N = 25) or second-generation (N = 36) oral antipsychotic during study participation. Treatment group designation (first-vs. second-generation antipsychotic) was based on the particular antipsychotic medication the patient was receiving as part of routine care at study entry (i.e., non-random assignment). Adherence to prescribed antipsychotic medication was assessed monthly over a 6-month study period using electronic monitoring (EM) of medication bottle opening. Various participant characteristics were collected at baseline to test for group differences and for potential associations with prospectively measured adherence. The primary data analysis was a mixed-model analysis of repeated measures. Results: The analysis of EM adherence revealed no significant difference between those taking first-generation (6-month adjusted mean adherence = 64.35{\%}) and second-generation antipsychotics (6-month adjusted mean adherence = 69.17{\%}; Group effect, p = .29) and no significant Group X Period interaction (p = .13). Conclusion: There was no statistical difference in EM adherence, over a 6-month period, between patients taking first- and second-generation antipsychotics. However, since the patients were not randomized, conclusions must be interpreted within the context of the quasi-experimental design used in the current study.",
keywords = "Antipsychotic medication adherence, Medication adherence, Schizophrenia",
author = "Nakonezny, {Paul A.} and Byerly, {Matthew J.}",
year = "2006",
month = "2",
day = "15",
doi = "10.1016/j.schres.2005.10.015",
language = "English (US)",
volume = "82",
pages = "107--114",
journal = "Schizophrenia Research",
issn = "0920-9964",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Electronically monitored adherence in outpatients with schizophrenia or schizoaffective disorder

T2 - A comparison of first- vs. second-generation antipsychotics

AU - Nakonezny, Paul A.

AU - Byerly, Matthew J.

PY - 2006/2/15

Y1 - 2006/2/15

N2 - Objective: To examine the effect of first- vs. second-generation antipsychotics on electronically monitored adherence in outpatients with schizophrenia or schizoaffective disorder. Method: The sample consisted of 61 outpatients with a DSM-IV diagnosis of schizophrenia or schizoaffective disorder who took either a first-generation (N = 25) or second-generation (N = 36) oral antipsychotic during study participation. Treatment group designation (first-vs. second-generation antipsychotic) was based on the particular antipsychotic medication the patient was receiving as part of routine care at study entry (i.e., non-random assignment). Adherence to prescribed antipsychotic medication was assessed monthly over a 6-month study period using electronic monitoring (EM) of medication bottle opening. Various participant characteristics were collected at baseline to test for group differences and for potential associations with prospectively measured adherence. The primary data analysis was a mixed-model analysis of repeated measures. Results: The analysis of EM adherence revealed no significant difference between those taking first-generation (6-month adjusted mean adherence = 64.35%) and second-generation antipsychotics (6-month adjusted mean adherence = 69.17%; Group effect, p = .29) and no significant Group X Period interaction (p = .13). Conclusion: There was no statistical difference in EM adherence, over a 6-month period, between patients taking first- and second-generation antipsychotics. However, since the patients were not randomized, conclusions must be interpreted within the context of the quasi-experimental design used in the current study.

AB - Objective: To examine the effect of first- vs. second-generation antipsychotics on electronically monitored adherence in outpatients with schizophrenia or schizoaffective disorder. Method: The sample consisted of 61 outpatients with a DSM-IV diagnosis of schizophrenia or schizoaffective disorder who took either a first-generation (N = 25) or second-generation (N = 36) oral antipsychotic during study participation. Treatment group designation (first-vs. second-generation antipsychotic) was based on the particular antipsychotic medication the patient was receiving as part of routine care at study entry (i.e., non-random assignment). Adherence to prescribed antipsychotic medication was assessed monthly over a 6-month study period using electronic monitoring (EM) of medication bottle opening. Various participant characteristics were collected at baseline to test for group differences and for potential associations with prospectively measured adherence. The primary data analysis was a mixed-model analysis of repeated measures. Results: The analysis of EM adherence revealed no significant difference between those taking first-generation (6-month adjusted mean adherence = 64.35%) and second-generation antipsychotics (6-month adjusted mean adherence = 69.17%; Group effect, p = .29) and no significant Group X Period interaction (p = .13). Conclusion: There was no statistical difference in EM adherence, over a 6-month period, between patients taking first- and second-generation antipsychotics. However, since the patients were not randomized, conclusions must be interpreted within the context of the quasi-experimental design used in the current study.

KW - Antipsychotic medication adherence

KW - Medication adherence

KW - Schizophrenia

UR - http://www.scopus.com/inward/record.url?scp=32044464094&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=32044464094&partnerID=8YFLogxK

U2 - 10.1016/j.schres.2005.10.015

DO - 10.1016/j.schres.2005.10.015

M3 - Article

C2 - 16376522

AN - SCOPUS:32044464094

VL - 82

SP - 107

EP - 114

JO - Schizophrenia Research

JF - Schizophrenia Research

SN - 0920-9964

IS - 1

ER -